Intersect ENT Inc

NASDAQ:XENT   3:59:58 PM EDT
21.85
+1.84 (+9.20%)
Other Pre-Announcement

Intersect Ent Announces Q2 Prelim Revenue Of About $27.3 Mln

Published: 07/22/2021 21:45 GMT
Intersect ENT Inc (XENT) - Intersect Ent Announces Preliminary Revenue for Second Quarter of 2021 and Closing of $60 Million Term Loan.
Sees FY Revenue $117 Million to $121 Million.
Q2 Prelim Revenue of About $27.3 Million.
Q2 Revenue Estimate $28 Million -- Refinitiv Ibes Data (analyst estimates).
Reiterates Full Year 2021 Revenue Guidance of $117 Million - $121 Million.
FY2021 Revenue View $119.8 Million -- Refinitiv Ibes Data (analyst estimates).
Further Company Coverage: .
((reuters.
Briefs@thomsonreuters.
Com;)).